IRIS - Res&Arch Institutional Research Information System - Research & Archive

COSTA, CINZIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.937
AS - Asia 3.550
EU - Europa 3.215
SA - Sud America 696
Continente sconosciuto - Info sul continente non disponibili 290
AF - Africa 111
OC - Oceania 8
Totale 12.807
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.754
SG - Singapore 1.565
IT - Italia 540
BR - Brasile 518
CN - Cina 506
HK - Hong Kong 505
IE - Irlanda 504
RU - Federazione Russa 418
VN - Vietnam 384
FR - Francia 371
UA - Ucraina 315
DE - Germania 245
SE - Svezia 227
FI - Finlandia 176
GB - Regno Unito 135
KR - Corea 119
CA - Canada 92
BD - Bangladesh 88
IN - India 82
AR - Argentina 65
NL - Olanda 61
TR - Turchia 40
IQ - Iraq 36
RO - Romania 36
MX - Messico 35
ID - Indonesia 30
JP - Giappone 30
PK - Pakistan 30
PL - Polonia 28
ZA - Sudafrica 27
AT - Austria 26
BE - Belgio 22
CO - Colombia 22
SA - Arabia Saudita 21
VE - Venezuela 20
CL - Cile 19
CZ - Repubblica Ceca 19
UZ - Uzbekistan 18
EC - Ecuador 17
LT - Lituania 17
CH - Svizzera 16
ES - Italia 16
MA - Marocco 16
DZ - Algeria 12
PH - Filippine 12
PY - Paraguay 12
EG - Egitto 11
JM - Giamaica 11
MY - Malesia 11
IL - Israele 9
KE - Kenya 9
LB - Libano 9
TN - Tunisia 9
BO - Bolivia 8
CR - Costa Rica 8
GR - Grecia 8
UY - Uruguay 8
AU - Australia 7
KZ - Kazakistan 7
PE - Perù 7
PS - Palestinian Territory 7
SC - Seychelles 7
AE - Emirati Arabi Uniti 6
ET - Etiopia 6
TT - Trinidad e Tobago 6
AL - Albania 5
AZ - Azerbaigian 5
EE - Estonia 5
EU - Europa 5
GT - Guatemala 5
HN - Honduras 5
PT - Portogallo 5
JO - Giordania 4
NI - Nicaragua 4
PR - Porto Rico 4
BB - Barbados 3
BG - Bulgaria 3
CI - Costa d'Avorio 3
KG - Kirghizistan 3
NP - Nepal 3
OM - Oman 3
RS - Serbia 3
BY - Bielorussia 2
CW - ???statistics.table.value.countryCode.CW??? 2
DM - Dominica 2
DO - Repubblica Dominicana 2
HU - Ungheria 2
KW - Kuwait 2
LV - Lettonia 2
MO - Macao, regione amministrativa speciale della Cina 2
PA - Panama 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
AD - Andorra 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BH - Bahrain 1
BS - Bahamas 1
BW - Botswana 1
Totale 12.499
Salva come PNG Salva come JPEG
Città #
Singapore 1.121
Chandler 566
Hong Kong 500
Dublin 499
San Jose 405
Ashburn 397
Santa Clara 210
Boardman 203
San Mateo 203
Jacksonville 171
Council Bluffs 157
Beijing 151
Moscow 148
Altamura 137
Perugia 137
Lauterbourg 129
Seoul 119
Medford 111
Princeton 109
Dong Ket 108
Lawrence 102
Munich 91
Los Angeles 89
Wilmington 86
Ann Arbor 82
Ho Chi Minh City 80
Andover 74
Hanoi 63
New York 61
The Dalles 59
Turku 58
Des Moines 52
São Paulo 52
Helsinki 48
Dallas 46
Piscataway 45
Phoenix 43
Redmond 43
Amsterdam 34
Frankfurt am Main 34
Montreal 31
London 30
Orem 27
Chicago 24
Atlanta 23
Houston 23
Rio de Janeiro 22
Tokyo 22
Brooklyn 21
San Paolo di Civitate 21
Warsaw 21
Brussels 20
Milan 20
Bucharest 19
Denver 19
Saint Petersburg 19
Nuremberg 18
Rome 18
Toronto 18
Woodbridge 18
Chennai 17
Norwalk 17
Johannesburg 16
Naples 16
Stockholm 16
Baghdad 15
Brasília 15
Charlotte 15
Florence 15
Haiphong 15
Boston 14
Buffalo 14
Poplar 14
Falkenstein 13
Mexico City 11
New Delhi 11
Riyadh 11
San Francisco 11
Tashkent 11
Campinas 10
Columbus 10
Curitiba 10
Da Nang 10
Izmir 10
Tianjin 10
Falls Church 9
Istanbul 9
Jakarta 9
New Orleans 9
Redwood City 9
Asunción 8
Belo Horizonte 8
Boydton 8
Kingston 8
Kuala Lumpur 8
Medellín 8
Santiago 8
Caracas 7
Goiânia 7
Guarulhos 7
Totale 7.706
Salva come PNG Salva come JPEG
Nome #
Alpha-Synuclein Produces Early Behavioral Alterations Via Striatal Cholinergic Synaptic Dysfunction by Interacting with GluN2D N-Methyl-D-Aspartate Receptor Subunit 226
A critical role of NO/cGMP/PKG dependent pathway in hippocampalpost-ischemic LTP: modulation by zonisamide. 154
Microglial activation and the nitric oxide/cGMP/PKG pathway underlie enhanced neuronal vulnerability to mitochondrial dysfunction in experimental multiple sclerosis 146
Brain arteriovenous malformations and seizures: an Italian study. 144
Decreased NR2B Subunit Synaptic Levels Cause Impaired Long-Term Potentiation But Not Long-Term Depression 143
Hippocampal epileptogenesis in autoimmune encephalitis 138
Interleukin-17 affects synaptic plasticity and cognition in an experimental model of multiple sclerosis 135
Electrophysiology and pharmacology of striatal neuronal dysfunction induced by mitochondrial complex I inhibition. 130
Epilepsy in hemiplegic migraine: Genetic mutations and clinical implications 130
c-Jun N-terminal Kinase regulates soluble Abeta oligomers and cognitive impairment in an AD mouse model. 129
A2A Adenosine Receptor Antagonism Enhances Synaptic and Motor Effects of Cocaine via CB1 Cannabinoid Receptor Activation. 129
Dopamine D2 receptor activation potently inhibits striatal glutamatergic transmission in a G2019S LRRK2 genetic model of Parkinson's disease 129
Evaluating bexicaserin for the treatment of developmental epileptic encephalopathies 128
Effects of central and peripheral inflammation on hippocampal synaptic plasticity 125
A2A adenosine receptor antagonists protect the striatum against rotenone-induced neurotoxicity 125
A novel ATP1A2 gene mutation in familial hemiplegic migraine and epilepsy. 124
Interaction of A2A adenosine and D2 dopamine receptors modulates corticostriatal glutamatergic transmission 124
Safety and efficacy of concomitant treatment with non-vitamin K antagonist oral anticoagulants and antiseizure medications: A propensity score matching cohort study 123
Alectinib's activity against CNS metastases from ALK-positive non-small cell lung cancer: a single institution case series 123
Alzheimer's disease and late-onset epilepsy of unknown origin: two faces of beta amyloid pathology 123
Low doses of Perampanel protect striatal and hippocampal neurons against in vitro ischemia by reversing the ischemia-induced alteration of AMPA receptor subunit composition 123
Persistent activation of microglia and NADPH drive hippocampal dysfunction in experimental multiple sclerosis 121
Critical role of calcitonin gene-related peptide receptors in cortical spreading depression. 121
Plasticity and repair in the post-ischemic brain 121
Occipital arteriovenous malformations andmigraine. 119
Endogenous 17β-estradiol is required for activity-dependent long-term potentiation in the striatum: interaction with the dopaminergic system 118
An Italian multicentre study of perampanel in progressive myoclonus epilepsies 118
Mechanisms underlying the impairment of hippocampal long-term potentiation and memory in experimental Parkinson's disease. 116
Management of epilepsy in brain tumors 116
Developmental impaired Akt signaling in the Shank1 and Shank3 double knock-out mice 116
Levetiracetam-associated hyponatremia. 115
Antiepileptic drugs on calcium currents recorded from cortical and PAG neurons: therapeutic implications for migraine. 115
Electrophysiological actions of zonisamide on striatal neurons: Selective neuroprotection against complex I mitochondrial dysfunction. 114
Cannabidiol: metabolism and clinical efficacy in epileptic patients 113
Differential effect of FHM2 mutation on synaptic plasticity in distinct hippocampal regions 112
Amyloid-β: a potential link between epilepsy and cognitive decline 112
A 1H magnetic resonance spectroscopy study in patients with obstructive sleep apnea. 111
Effect of Brivaracetam on Efficacy and Tolerability in Patients With Brain Tumor-Related Epilepsy: A Retrospective Multicenter Study 107
Epilepsy, amyloid-β, and D1 dopamine receptors: a possible pathogenetic link? 104
Memantine reduces neuronal dysfunctions triggered by in vitro ischemia and 3-nitropropionic acid. 103
Lacosamide protects striatal and hippocampal neurons from in vitro ischemia without altering physiological synaptic plasticity 103
Synaptic vesicle protein 2A tumoral expression predicts levetiracetam adverse events 103
Liverpool Adverse Events Profile: Italian validation and predictive value for dropout from antiepileptic treatment in people with epilepsy 103
Sleep disorders and late-onset epilepsy of unknown origin: Understanding new trajectories to brain amyloidopathy 103
Ischemic-LTP in striatal spiny neurons of both direct and indirect pathway requires the activation of D1-like receptors and NO/soluble guanylate cyclase/cGMP transmission. 102
Region- and age-dependent reductions of hippocampal long-term potentiation and NMDA to AMPA ratio in a genetic model of Alzheimer's disease. 102
HCN ion channels and accessory proteins in epilepsy: genetic analysis of a large cohort of patients and review of the literature 102
MBOAT7 encephalopathy: Characterizing the neurology and epileptology 101
Effect of psychotropic drugs on seizure threshold 101
Hippocampal synaptic plasticity, memory, and epilepsy: effects of long-term valproic acid treatment. 101
Cortical spreading depression as a target for anti-migraine agents. 101
Mechanisms underlying altered striatal synaptic plasticity in old A53T-α synuclein overexpressing mice. 100
Rapid effect of levetiracetam in a case of juvenile myoclonic epilepsy 99
Neural 17beta-estradiol facilitates long-term potentiation in the hippocampal CA1 region 99
Enhanced sensitivity of DJ-1-deficient dopaminergic neurons to energy metabolism impairment: Role of Na(+)/K(+) ATPase. 96
O064. Antiepileptic drugs in migraine and epilepsy disorders: who is at increased risk of adverse events? 96
Obsessive-compulsive disorder and migraine with medication-overuse headache. 96
The distinct role of medium spiny neurons and cholinergic interneurons in the D₂/A₂A receptor interaction in the striatum: implications for Parkinson's disease. 95
Cognitive performances in patients affected by late-onset epilepsy with unknown etiology: A 12-month follow-up study 95
CAR T cell-driven cerebrospinal fluid cytokine storm with confounding neurological picture in chemorefractory primary cardiac lymphoma 95
Erratum: Persistent activation of microglia and NADPH oxidase drive hippocampal dysfunction in experimental multiple sclerosis (Scientific Reports (2016) 6 (20926) DOI: 10.1038/srep20926) 94
Temporal lobe dysfunction in late-onset epilepsy of unknown origin 92
Multiple mechanisms underlying the neuroprotective effects of antiepileptic drugs against in vitro ischemia. 91
Incidence and Antiseizure Medications of Post-stroke Epilepsy in Umbria: A Population-Based Study Using Healthcare Administrative Databases 91
Chronic haloperidol promotes corticostriatal long-term potentiation by targeting dopamine D2L receptors. 90
Hyperhomocysteinemia and retinal vascular changes in patients with epilepsy. 89
Striatal spreading depolarization: Possible implication in levodopa-induced dyskinetic-like behavior 89
Late-Onset Epilepsy With Unknown Etiology: A Pilot Study on Neuropsychological Profile, Cerebrospinal Fluid Biomarkers, and Quantitative EEG Characteristics 89
Neuropsychiatric adverse events of antiepileptic drugs in brain tumour-related epilepsy: an Italian multicentre prospective observational study 88
Two-year longitudinal monitoring of amnestic mild cognitive impairment patients with prodromal Alzheimer's disease using topographical biomarkers derived from functional magnetic resonance imaging and electroencephalographic activity 88
Clinical and Instrumental Characterization of Patients With Late-Onset Epilepsy 87
Late onset epilepsy and Alzheimer's disease: exploring the dual pathogenic role of amyloid-β 86
An unbalanced synaptic transmission: Cause or consequence of the amyloid oligomers neurotoxicity? 86
Chronic cocaine prevents depotentiation at corticostriatal synapses. 85
Cognitive Decline Risk Stratification in People with Late-Onset Epilepsy of Unknown Etiology: An Electroencephalographic Connectivity and Graph Theory Pilot Study 84
Neuroprotection as a potential therapeutic perspective in neurodegenerative diseases: Focus on antiepileptic drugs 84
Degradation of endocannabinoids in chronic migraine and medication overuse headache. 83
Na+/Ca2+ exchanger maintains ionic homeostasis in the peri-infarct area. 83
Antiepileptic drugs in migraine and epilepsy: Who is at increased risk of adverse events? 83
A loss-of-function HCN4 mutation associated with familial benign myoclonic epilepsy in infancy causes increased neuronal excitability 83
Striatal spreading depolarization: Possible implication in levodopa-induced dyskinetic-like behavior 83
Hyperhomocysteinemia in epileptic patients on new antiepileptic drugs. 82
Epm2aR240X knock-in mice present earlier cognitive decline and more epileptic activity than Epm2a-/- mice 81
Environmental enrichment restores CA1 hippocampal LTP and reduces severity of seizures in epileptic mice. 81
Migraine and epilepsy: what value today? 80
Expanding the phenotype of ASXL3-related syndrome: A comprehensive description of 45 unpublished individuals with inherited and de novo pathogenic variants in ASXL3 80
IRF2BPL: A new genotype for progressive myoclonus epilepsies 79
Levetiracetam in newly diagnosed late-onset post-stroke seizures: a prospective observational study. 79
Clinical features and outcome of 6 new patients carrying de novoKCNB1gene mutations 78
Valproic Acid and Epilepsy: From Molecular Mechanisms to Clinical Evidences 78
Distinct roles for spinophilin and neurabin in dopamine-mediated plasticity. 77
Upfront pembrolizumab as an effective treatment start in patients with PD-L1 ≥ 50% non-oncogene addicted non-small cell lung cancer and asymptomatic brain metastases: an exploratory analysis 77
Corticostriatal LTP requires combined mGluR1 and mGluR5 activation. 76
CalDAG-GEFI mediates striatal cholinergic modulation of dendritic excitability, synaptic plasticity and psychomotor behaviors 74
Gene therapy for Lafora disease in the Epm2a-/- mouse model 73
Locally Synthetized 17-β-Estradiol Reverses Amyloid-β-42-Induced Hippocampal Long-Term Potentiation Deficits 73
Ionotropic glutamate receptors: still a target for neuroprotection in brain ischemia? Insights from in vitro studies. 73
Coactivation of GABA(A) and GABA(B) receptor results in neuroprotection during in vitro ischemia. 73
Dopaminergic and Behavioral Deficits Caused by Inactivation of the Familial Parkinsonism-Linked Gene DJ-1 72
Impaired plasticity at specific subset of striatal synapses in the Ts65Dn mouse model of Down syndrome. 72
Totale 10.302
Salva come PNG Salva come JPEG
Categoria #
all - tutte 59.893
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.893
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022688 0 0 0 42 33 13 13 262 19 54 124 128
2022/20231.831 118 377 33 150 165 195 0 67 656 8 45 17
2023/2024803 43 75 34 10 3 3 177 11 117 26 152 152
2024/20251.921 25 162 91 122 220 118 92 154 328 121 324 164
2025/20264.814 296 330 327 649 694 392 728 255 476 400 174 93
2026/2027934 95 260 311 268 0 0 0 0 0 0 0 0
Totale 12.807